Monocytes and Macrophages in Alpha-1 Antitrypsin Deficiency

References

• StockleyRA. Alpha1-antitrypsin review. Clin Chest Med. 2014;35(1):39–50. doi:10.1016/j.ccm.2013.10.00124507836
   PubMed Web of Science ®Google Scholar
• BerginDA, HurleyK, McElvaneyNG. Alpha-1 antitrypsin: a potent anti-inflammatory and potential novel therapeutic agent. Arch Immunol Ther Exp. 2012;60:81–97. doi:10.1007/s00005-012-0162-5
   PubMed Web of Science ®Google Scholar
• DickensJA, LomasDA. Why has it been so difficult to prove the efficacy of alpha-1-antitrypsin replacement therapy? Insights from the study of disease pathogenesis. Drug Des Devel Ther. 2011;5:391–405.
   PubMed Web of Science ®Google Scholar
• StockleyRA. Neutrophils and Protease/Antiprotease Imbalance. Am J Respir Crit Care Med. 1999;160(1):S49–S52. doi:10.1164/ajrccm.160.supplement_1.1310556170
   PubMed Web of Science ®Google Scholar
• HillAT, BayleyDL, CampbellEJ, HillSL, StockleyRA. Airways inflammation in chronic bronchitis: the effects of smoking and alpha1-antitrypsin deficiency. Eur Respir J. 2000;15(5):886–890. doi:10.1034/j.1399-3003.2000.15e12.x10853853
   PubMed Web of Science ®Google Scholar
• StollerJK, AboussouanLS. A review of α1-antitrypsin deficiency. Am J Respir Crit Care Med. 2012;185(3):246–259. doi:10.1164/rccm.201108-1428CI21960536
   PubMed Web of Science ®Google Scholar
• BlancoI, DiegoI, BuenoP, Perez-HolandaS, Cases-MaldonadoF, MiravitllesM. Prevalence of α1-antitrypsin PiZZ genotypes in patients with COPD in Europe: a systematic review. Eur Respir Rev. 2020;29(157):200014. doi:10.1183/16000617.0014-202032699024
   PubMed Web of Science ®Google Scholar
• Society AT, Society ER. American Thoracic Society/European Respiratory Society statement: standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency; 2003.
   Google Scholar
• TanL, DickensJA, DeMeoDL, et al. Circulating polymers in α1-antitrypsin deficiency. Eur Respir J. 2014;43:1501–1504. doi:10.1183/09031936.0011121324603821
   PubMed Web of Science ®Google Scholar
• LiebermanJ, WinterB, SastreA. Alpha-1 antritrypsin Pi-types in 965 COPD patients. Chest. 1986;89(3):370–373. doi:10.1378/chest.89.3.3703485034
   PubMed Web of Science ®Google Scholar
• FranciosiAN, HobbsBD, McElvaneyOJ, et al. Clarifying the risk of lung disease in SZ Alpha-1 antitrypsin deficiency. Am J Respir Crit Care Med. 2020;202(1):73–82. doi:10.1164/rccm.202002-0262OC32197047
   PubMed Web of Science ®Google Scholar
• HaqI, IrvingJA, SalehAD, et al. Deficiency mutations of Alpha-1 antitrypsin. Effects on folding, function, and polymerization. Am J Respir Crit Care Med. 2016;54(1).
   Google Scholar
• RogersJ, KalshekerN, WallisS, et al. The isolation of a clone for human alpha1-antitrypsin and the detection of alpha 1-antitrypsin in mRNA from liver and leukocytes. Biochem Biophys Res Commun. 1983;116(2):375–382. doi:10.1016/0006-291X(83)90532-66606425
   PubMed Web of Science ®Google Scholar
• CichyJ, PotempaJ, TravisJ. Biosynthesis of alpha 1 proteinase inhibitor by human lung-derived epithelial cells. J Biol Chem. 1997;272(13):8250–8255. doi:10.1074/jbc.272.13.82509079644
   PubMed Web of Science ®Google Scholar
• BerginDA, ReevesEP, MeleadyP, et al. Alpha-1 antitrypsin regulates human neutrophil chemotaxis induced by soluble immune complexes and IL-8. J Clin Invest. 2010;120(12):4236–4250. doi:10.1172/JCI4119621060150
   PubMed Web of Science ®Google Scholar
• Du BoisRM, BernaudinJF, PaakkoP, et al. Human neutrophils express the alpha 1-antitrypsin gene and produce alpha 1-antitrypsin. Blood. 1991;77(12):2724–2730. doi:10.1182/blood.V77.12.2724.27242043769
   PubMed Web of Science ®Google Scholar
• MolmentiEP, PerlmutterDH, RubinDC. Cell-specific expression of alpha 1-antitrypsin in human intestinal epithelium. J Clin Invest. 1993;92(4):2022–2034. doi:10.1172/JCI1167978408656
   PubMed Web of Science ®Google Scholar
• BoscoD, MedaP, MorelP, et al. Expression and secretion of alpha1- proteinase inhibitor are regulated by proinflammatory cytokines in human pancreatic islet cells. Diabetologia. 2005;48(8):1523–1533. doi:10.1007/s00125-005-1816-116001235
   PubMed Web of Science ®Google Scholar
• MulgrewAT, TaggartCC, LawlessMW, et al. Z alpha1-antitrypsin polymerizes in the lung and acts as a neutrophil chemoattractant. Chest. 2004;125(5):1952–1957. doi:10.1378/chest.125.5.195215136414
   PubMed Web of Science ®Google Scholar
• MahadevaR, AtkinsonC, LiZ, et al. Polymers of Z alpha1-antitrypsin co-localize with neutrophils in emphysematous alveoli and are chemotactic in vivo. Am J Pathol. 2005;166(2):377–386. doi:10.1016/S0002-9440(10)62261-415681822
   PubMed Web of Science ®Google Scholar
• ElliottPR, BiltonD, LomasDA. Lung polymers in Z alpha1-antitrypsin deficiency-related emphysema. Am J Respir Cell Mol Biol. 1998;18(5):670–674. doi:10.1165/ajrcmb.18.5.30659569237
   PubMed Web of Science ®Google Scholar
• ParrDG, StoelBC, StolkJ, StockleyRA. Pattern of emphysema distribution in α1-antitrypsin deficiency influences lung function impairment. Am J Respir Crit Care Med. 2004;170(11):1172–1178. doi:10.1164/rccm.200406-761OC15306534
   PubMed Web of Science ®Google Scholar
• JanciauskieneS, WrengerS, ImmenschuhS, et al. The multifaceted effects of Alpha1-antitrypsin on neutrophil functions. Front Pharmacol. 2018;9:341. doi:10.3389/fphar.2018.0034129719508
   PubMed Web of Science ®Google Scholar
• McCarthyC, ReevesEP, McElvaneyNG. The role of neutrophils in Alpha-1 antitrypsin deficiency. Ann Am Thorac Soc. 2015;13(4):297–304. doi:10.1513/AnnalsATS.201509-634KV
   Web of Science ®Google Scholar
• CarrollTP, GreeneCM, O’ConnorCA, NolanAM, O’NeillSJ, McElvaneyNG. Evidence for unfolded protein response activation in monocytes from individuals with a-1 antitrypsin deficiency. J Immunol. 2010;184:4538–4546. doi:10.4049/jimmunol.080286420228200
   PubMed Web of Science ®Google Scholar
• BazzanE, TineM, BiondiniD, et al. α1-Antitrypsin Polymerizes in Alveolar Macrophages of Smokers With and Without α1-Antitrypsin Deficiency. Chest. 2018;154(3):607–616. doi:10.1016/j.chest.2018.04.03929763589
   PubMed Web of Science ®Google Scholar
• KarlmarkKR, TackeF, DunayIR. Monocytes in health and disease – mini review. Eur J Microbiol Immunol (Bp). 2012;2(2):97–102. doi:10.1556/EuJMI.2.2012.2.124672677
   PubMedGoogle Scholar
• KapellosTS, BonaguroL, GemundI, et al. Human monocyte subsets and phenotypes in major chronic inflammatory diseases. Front Immunol. 2019;10. doi:10.3389/fimmu.2019.02035
   PubMed Web of Science ®Google Scholar
• PasslickB, FliegerD, Ziegler-HeitbrockL. Identification and characterization of a novel monocyte subpopulation in human peripheral blood. Blood. 1989;74(7):2527–2534. doi:10.1182/blood.V74.7.2527.25272478233
   PubMed Web of Science ®Google Scholar
• WongKL, TaiJ, WongWC, et al. Gene expression profiling reveals the defining features of the classical, intermediate, and nonclassical human monocyte subsets. Blood. 2011;118(5):16–31. doi:10.1182/blood-2010-12-326355
   PubMed Web of Science ®Google Scholar
• PerlmutterDH, ColeFS, KilbridgeP, RossingTH, ColtenHR. Expression of the a1-proteinase inhibitor gene in human monocytes and macrophages. Proc Natl Acad Sci. 1985;82:798–799. doi:10.1073/pnas.82.3.795
   Web of Science ®Google Scholar
• PerlmutterDH, TravisJ, PunsalPI. Elastase regulates the synthesis of its inhibitor, alpha 1-proteinase inhibitor, and exaggerates the defect in homozygous PiZZ alpha 1 PI deficiency. J Clin Invest. 1988;81(6):1774–1780. doi:10.1172/JCI1135193260245
   PubMed Web of Science ®Google Scholar
• MornexJF, Chytil-WeirA, MartinetY, CourtneyM, LeCocqJP, CrystalRG. Expression of the alpha-1-antitrypsin gene in mononuclear phagocytes of normal and alpha-1-antitrypsin-deficient individuals. J Clin Invest. 1986;77(6):1952–1961. doi:10.1172/JCI1125243486887
   PubMed Web of Science ®Google Scholar
• JanciauskieneS, LarssonS, LarssonP, VirtalaR, JanssonL, StevensT. Inhibition of lipopolysaccharide-mediated human monocyte activation, in vitro, by a1-antitrypsin. Biochem Biophys Res Commun. 2004;321:592–600. doi:10.1016/j.bbrc.2004.06.12315358147
   PubMed Web of Science ®Google Scholar
• NitaIM, SerapinasD, JanciauskieneS. alpa1-Antitrypsin regulates CD14 expression and soluble CD14 levels in human monocytes in vitro. Int J Biochem Cell Biol. 2007;39:1165–1176. doi:10.1016/j.biocel.2007.02.01717448722
   PubMed Web of Science ®Google Scholar
• JanciauskieneS, NitaIM, StevensT. Alpha1-antitrypsin exerts in vitro anti-inflammatory activity in human monocytes by elevating cAMP. J Biol Chem. 2007;282(12):8573–8582. doi:10.1074/jbc.M60797620017261591
   PubMed Web of Science ®Google Scholar
• OlingyCE, San EmeterioCL, OgleME, et al. Non-classical monocytes are biased progenitors of wound healing macrophages during soft tissue injury. Sci Rep. 2017;7:447. doi:10.1038/s41598-017-00477-128348370
   PubMed Web of Science ®Google Scholar
• ThomasG, TackeR, HedrickCC, HannaRN. Nonclassical patrolling monocyte function in the vasculature. Arterioscler Thromb Vasc Biol. 2015;35(6):1306–1316. doi:10.1161/ATVBAHA.114.30465025838429
   PubMed Web of Science ®Google Scholar
• StolkJ, AggarwalAN, HochnadelI, et al. Blood monocyte profiles in COPD patients with PiMM and PiZZ α1-antitrypsin. Respir Med. 2019;148:60–62. doi:10.1016/j.rmed.2019.02.00130827477
   PubMed Web of Science ®Google Scholar
• StockleyRA, EdgarRG, PillaiA, TurnerAM. Individualized lung function trends in alpha-1-antitrypsin deficiency: a need for patience in order to provide patient centered management? Int J Chron Obstruct Pulmon Dis. 2016;11:1745–1756. doi:10.2147/COPD.S11150827536086
   PubMed Web of Science ®Google Scholar
• MurrayPJ, AllenJE, BiswasSK, et al. Macrophage activation and polarization: nomenclature and experimental guidelines. Immunity. 2014;41(1):14–20. doi:10.1016/j.immuni.2014.06.00825035950
   PubMed Web of Science ®Google Scholar
• MantovaniA, BiswalS, GaldieroMR, SicaA, LocatiM. Macrophage plasticity and polarization in tissue repair and remodelling. J Pathol. 2013;229(2):176–185. doi:10.1002/path.413323096265
   PubMed Web of Science ®Google Scholar
• Van’t WoutEFA, van SchadewijkA, SavageNDL, StolkJ, HiemstraPS. Alpha-1 antitrypsin production by proinflammatory and antiinflammatory macrophages and dendritic cells. Am J Respir Cell Mol Biol. 2012;46(5):607–613. doi:10.1165/rcmb.2011-0231OC22162908
   PubMed Web of Science ®Google Scholar
• HubbardRC, FellsG, GadekJ, PacholokS, HumesJ, CrystalRG. Neutrophil accumulation in the lung in alpha 1-antitrypsin deficiency. Spontaneous release of leukotriene B4 by alveolar macrophages. J Clin Invest. 1991;88(3):891–897. doi:10.1172/JCI1153911653278
   PubMed Web of Science ®Google Scholar
• CrooksSW, BayleyDL, HillSL, StockleyRA. Bronchial inflammation in acute bacterial exacerbations of chronic bronchitis: the role of leukotriene B4. Eur Respir J. 2000;15(2):274–280. doi:10.1034/j.1399-3003.2000.15b09.x10706491
   PubMed Web of Science ®Google Scholar
• WoolhouseIS, BayleyDL, StockleyRA. Sputum chemotactic activity in chronic obstructive pulmonary disease: effect of alpha(1)-antitrypsin deficiency and the role of leukotriene B(4) and interleukin 8. Thorax. 2002;57(8):709–714. doi:10.1136/thorax.57.8.70912149532
   PubMed Web of Science ®Google Scholar
• StockleyRA, BayleyDL, UnsalI, DowsonLJ. The effect of augmentation therapy on bronchial inflammation in alpha1-antitrypsin deficiency. Am J Respir Crit Care Med. 2002;165(11):1494–1498. doi:10.1164/rccm.210901312045122
   PubMed Web of Science ®Google Scholar
• SerbanKA, PetruscaDN, MikoszA, et al. Alpha-1 antitrypsin supplementation improves alveolar macrophages efferocytosis and phagocytosis following cigarette smoke exposure. PLoS One. 2017;12(4):e0176073. doi:10.1371/journal.pone.017607328448535
   PubMed Web of Science ®Google Scholar
• VandivierRW, FadokVA, HoffmannPR, et al. Elastase-mediated phosphatidylserine receptor cleavage impairs apoptotic cell clearance in cystic fibrosis and bronchiectasis. J Clin Invest. 2002;109(5):661–670. doi:10.1172/JCI021357211877474
   PubMed Web of Science ®Google Scholar
• ChanED, KaminskaAM, GillW, et al. Alpha-1-antitrypsin (AAT) anomalies are associated with lung disease due to rapidly growing mycobacteria and AAT inhibits Mycobacterium abscessus infection of macrophages. Scand J Infect Dis. 2007;39:690–696. doi:10.1080/0036554070122574417654345
   PubMed Web of Science ®Google Scholar
• KrotovaK, MarekGW, WangRL, et al. Alpha-1 antitrypsin-deficient macrophages have increased matriptase-mediated proteolytic activity. Am J Respir Cell Mol Biol. 2017;57(2):238–247. doi:10.1165/rcmb.2016-0366OC28362108
   PubMed Web of Science ®Google Scholar
• BelchamberKBR, DonnellyLE. Macrophage function in respiratory disease In: KlocM, editor. Macrophages: Origin, Functions and Biointervention. Results and Problems in Cell Differentiation. Vol. 62 Springer; 2017:299–313.
   Google Scholar
• TaylorAE, Finney-HaywardTK, QuintJK, et al. Defective macrophage phagocytosis of bacteria in COPD. Eur Respir J. 2010;35(5):1039–1047. doi:10.1183/09031936.0003670919897561
   PubMed Web of Science ®Google Scholar
• BerensonCS, GarlippMA, GroveLJ, MaloneyJ, SethiS. Impaired phagocytosis of nontypeable Haemophilus influenzae by human alveolar macrophages in chronic obstructive pulmonary disease. J Infect Dis. 2006;194(10):1375–1384. doi:10.1086/50842817054066
   PubMed Web of Science ®Google Scholar
• WrenchC, BelchamberKBR, BercussonA, ShahA, BarnesPJ, DonnellyLE. Reduced clearance of fungal spores by COPD GM-CSF and M-CSF derived macrophages. Am J Respir Cell Mol Biol. 2018;58(2):271–273. doi:10.1165/rcmb.2017-0351LE29388829
   PubMed Web of Science ®Google Scholar
• HodgeS, HodgeG, ScicchitanoR, ReynoldsPN, HolmesM. Alveolar macrophages from subjects with chronic obstructive pulmonary disease are deficient in their ability to phagocytose apoptotic airway epithelial cells. Immunol Cell Biol. 2003;81(4):289–296. doi:10.1046/j.1440-1711.2003.t01-1-01170.x12848850
   PubMed Web of Science ®Google Scholar
• BelchamberKBR, SinghR, BatistaCM, et al. Defective bacterial phagocytosis is associated with dysfunctional mitochondria in COPD. Eur Respir J. 2019;54(3). doi:10.1183/13993003.02244-2018.
   PubMed Web of Science ®Google Scholar
• ChertovO, UedaH, XuL, et al. Identification of human neutrophil-derived cathepsin G and azurocidin/CAP37 as chemoattractants for mononuclear cells and neutrophils. J Exp Med. 1997;186(5):739–747. doi:10.1084/jem.186.5.7399271589
   PubMed Web of Science ®Google Scholar
• SoehnleinO, LindbornL. Neutrophil‐derived azurocidin alarms the immune system. J Leukoc Biol. 2008;85(3).
   PubMed Web of Science ®Google Scholar
• YangW, TaoY, WuY, et al. Neutrophils promote the development of reparative macrophages mediated by ROS to orchestrate liver repair. Nat Commun. 2019;10.
   Web of Science ®Google Scholar
• MarwickJA, MillsR, KayO, et al. Neutrophils induce macrophage anti-inflammatory reprogramming by suppressing NF-κB activation. Cell Death Dis. 2018;9. doi:10.1038/s41419-018-0710-y
   PubMed Web of Science ®Google Scholar
• MartinSJ, ReutelingspergerCP, McGahonAJ, et al. Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl. J Exp Med. 1995;185(5):1454–1456.
   Google Scholar
• ScannellM, FlanaganMB, deStephaniA, et al. Annexin-1 and peptide derivatives are released by apoptotic cells and stimulate phagocytosis of apoptotic neutrophils by macrophages. J Immunol. 2007;178(7):4595–4605. doi:10.4049/jimmunol.178.7.459517372018
   PubMed Web of Science ®Google Scholar
• KobayashiN, KarisolaP, Pena-CruzV, et al. TIM-1 and TIM-4 glycoproteins bind phosphatidylserine and mediate uptake of apoptotic cells. Immunity. 2007;27(6):927–940. doi:10.1016/j.immuni.2007.11.01118082433
   PubMed Web of Science ®Google Scholar
• FadokVA, BrattonDL, KonowalA, FreedPW, WestcottJY, HensonPM. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J Clin Invest. 1998;101(4):890–898. doi:10.1172/JCI11129466984
   PubMed Web of Science ®Google Scholar
• HurleyK, LaceyN, O’DwyerCA, et al. Alpha-1 antitrypsin augmentation therapy corrects accelerated neutrophil apoptosis in deficient individuals. J Immunol. 2014;193:3979–3991. doi:10.4049/jimmunol.1400132
   Web of Science ®Google Scholar
• EdgarRG, PatelM, BaylissS, CrossleyD, SapeyE, TurnerAM. Treatment of lung disease in alpha-1 antitrypsin deficiency: a systematic review. Int J Chron Obstruct Pulmon Dis. 2017;12:1295–1308. doi:10.2147/COPD.S13044028496314
   PubMed Web of Science ®Google Scholar
• ChapmanKR, StockleyRA, DawkinsC, WilkesMN, NavickisRJ. Augmentation therapy for alpha1 antitrypsin deficiency: a meta-analysis. COPD. 2009;6(3):177–184. doi:10.1080/1541255090290596119811373
   PubMedGoogle Scholar
• TonelliAR, BrantlyML. Augmentation therapy in alpha-1 antitrypsin deficiency: advances and controversies. Ther Adv Respir Dis. 2010;4(5):289–312. doi:10.1177/175346581037391120650978
   PubMedGoogle Scholar
• BaiX, BaiA, HondaJR, et al. Alpha-1-antitrypsin enhances primary human macrophage immunity against non-tuberculous mycobacteria. Front Immunol. 2019;10. doi:10.3389/fimmu.2019.01417
   Web of Science ®Google Scholar
• FerrarottiI, OttavianiS, De SilvestriA, CorsicoAG. Update on α 1 -antitrypsin deficiency. Breathe. 2018;14:17–24. doi:10.1183/20734735.015018
   Web of Science ®Google Scholar
• BurrowsJA, WillisLK, PerlmutterDH. Chemical chaperones mediate increased secretion of mutant alpha 1-antitrypsin (alpha 1-AT) Z: a potential pharmacological strategy for prevention of liver injury and emphysema in alpha 1-AT deficiency. Proc Natl Acad Sci. 2000;97(4):1796–1801. doi:10.1073/pnas.97.4.179610677536
   PubMed Web of Science ®Google Scholar
• LoffingJ, MoyerBD, ReynoldsD. PBA increases CFTR expression but at high doses inhibits Cl(-) secretion in Calu-3 airway epithelial cells. Am J Physiol. 1999;227(4):700–708.
   Google Scholar
• MahadevaR, DaffronTR, CarrellRW, LomasDA. 6-mer peptide selectively anneals to a pathogenic serpin conformation and blocks polymerization. J Biol Chem. 2001;277:6771–6774. doi:10.1074/jbc.C10072220011773044
   PubMed Web of Science ®Google Scholar
• PyeA, TurnerAM. Experimental and investigational drugs for the treatment of alpha-1 antitrypsin deficiency. Expert Opin Investig Drugs. 2019;28(10):891–902. doi:10.1080/13543784.2019.1672656
   PubMed Web of Science ®Google Scholar